Improving the representativeness of influenza viruses shared within the WHO Global Influenza Surveillance and Response System

Influenza and other Respiratory Viruses

Volumn 10, Issue 2, 2016, Pages 68-75

  Pereyaslov, Dmitriy ^a   Zemtsova, Galina ^a   Gruessner, Christine ^a   Daniels, Rodney S ^b   Mccauley, John W ^b   Brown, Caroline S ^a  

^a WHO REGIONAL OFFICE FOR EUROPE   (Denmark)

^b THE FRANCIS CRICK INSTITUTE   (United Kingdom)

Author keywords

Influenza vaccine virus selection; Influenza vaccine viruses; WHO recommendations

Indexed keywords

ARTICLE; BIOGEOGRAPHIC REGION; EPIDEMIOLOGICAL MONITORING; EUROPE; INFLUENZA A VIRUS; INFLUENZA B VIRUS; MEDICAL RESEARCH; NATIONAL HEALTH ORGANIZATION; NATIONAL INFLUENZA CENTER; NONHUMAN; PRIORITY JOURNAL; PROTOCOL COMPLIANCE; SEASONAL VARIATION; SHIPPING; VACCINE PRODUCTION; VIRUS IDENTIFICATION; VIRUS STRAIN; WORLD HEALTH ORGANIZATION; CLASSIFICATION; COOPERATION; ENGLAND; HEALTH SURVEY; HUMAN; INFLUENZA A VIRUS (H1N1); INFLUENZA A VIRUS (H3N2); INFLUENZA, HUMAN; ISOLATION AND PURIFICATION; ORTHOMYXOVIRIDAE; SEASON; VIROLOGY;

INFLUENZA VACCINE;

COOPERATIVE BEHAVIOR; EUROPE; HUMANS; INFLUENZA A VIRUS, H1N1 SUBTYPE; INFLUENZA A VIRUS, H3N2 SUBTYPE; INFLUENZA B VIRUS; INFLUENZA VACCINES; INFLUENZA, HUMAN; LONDON; ORTHOMYXOVIRIDAE; POPULATION SURVEILLANCE; SEASONS; WORLD HEALTH ORGANIZATION;

EID: 84957876857     PISSN: 17502640     EISSN: 17502659     Source Type: Journal    
DOI: 10.1111/irv.12362     Document Type: Article

References (18)

1. Salomon R, Webster RG. The influenza virus enigma. Cell 2009; 136:402-410.
2. World Health Organization. The virology and epidemiology, control and surveillance of influenza; WHO global influenza surveillance network: manual for the laboratory diagnosis and virological surveillance of influenza. Geneva: World Health Organization, 2011; 1-27.
3. Cox NJ, Subbarao K. Global epidemiology of influenza: past and present. Annu Rev Med 2000; 51:407-421.
4. World Health Organization. Global Influenza Surveillance and Response System (GISRS). Geneva: World Health Organization. Available at http://www.who.int/influenza/gisrs_laboratory/en/ (Accessed 8 June, 2015).
5. World Health Organization. Influenza vaccine viruses and reagents. Geneva:World Health Organization. Available at http://www.who.int/influenza/vaccines/virus/en/ (Accessed 8 June, 2015).
6. World Health Organization. WHO recommendations on the composition of influenza virus vaccines. Geneva: World Health Organization. Available at http://www.who.int/influenza/vaccines/virus/recommendations/en/ (Accessed 8 June, 2015).
7. WHO Regional Office for Europe Influenza Surveillance Platform (EuroFlu). Copenhagen: World Health Organization Regional Office for Europe. Available at http://www.euroflu.org (Accessed 15 July, 2014).
8. World Health Organization. Selection of clinical specimens for virus isolation and of viruses for shipment from National Influenza Centres to WHO Collaborating Centres. Geneva: World Health Organization. 6 December 2010. Available at http://www.who.int/influenza/gisrs_laboratory/national_influenza_centres/20101206_specimens_selected_for_virus_isolation_and_shipment.pdf (Accessed 8 June, 2015).
9. World Health Organization. Pandemic influenza preparedness framework for the sharing of influenza viruses and access to vaccines and other benefits. Geneva: World Health Organization; 2011.
10. Composition of macro geographical (continental) regions, geographical sub-regions, and selected economic and other groupings. New York: United Nations. 31 October 2013. Available at http://unstats.un.org/UNSD/METHODS/M49/M49REGIN.HTM (Accessed 8 June, 2015).
11. WHO. Regional Office for Europe. Summary of the first post-pandemic influenza season in the WHO European Region: 2010-2011. WHO Regional Office for Europe. Available at http://www.euro.who.int/en/health-topics/communicable-diseases/influenza/publications/2011/summary-of-the-first-post-pandemic-influenza-season-in-the-who-european-region-2010-2011 (Accessed 8 June, 2015).
12. WHO. Regional Office for Europe. Summary of the 2011-2012 influenza season in the WHO European Region. WHO Regional Office for Europe. Available at http://www.euro.who.int/en/health-topics/communicable-diseases/influenza/publications/2012/summary-of-the-2011-2012-influenza-season-in-the-who-european-region (Accessed 8 June, 2015).
13. Martirosyan L, Paget WJ, Jorgensen P et al. The community impact of the 2009 influenza pandemic in the WHO European region: a comparison with historical seasonal data from 28 countries. BMC Infect Dis 2012; 12:36.
14. Lin YP, Xiong X, Wharton SA et al. Evolution of the receptor binding properties of the influenza A(H3N2) hemagglutinin. Proc Natl Acad Sci U S A 2012; 109:21474-21479.
15. World Health Organization. Terms of reference for National Influenza Centres. Geneva: World Health Organization. Available at http://www.who.int/entity/influenza/gisrs_laboratory/national_influenza_centres/terms_of_reference:for_national_influenza_centres.pdf (Accessed 8 June, 2015).
16. World Health Organization. 3rd WHO Informal Consultation for Improving Influenza Vaccine Virus Selection. Geneva: World Health Organization. Available at http://www.who.int/influenza/vaccines/virus/3rdmtg_improve_vaccine_virus_selection/en/ (Accessed 8 June, 2015).
17. Ampofo WK, Al Busaidy S, Cox NJ et al. Strengthening the influenza vaccine virus selection and development process: outcome of the 2nd WHO Informal Consultation for Improving Influenza Vaccine Virus Selection held at the Centre International de Conferences (CICG) Geneva, Switzerland, 7 to 9 December 2011. Vaccine 2013; 31:3209-3221.
18. Ampofo WK, Baylor N, Cobey S et al. Improving influenza vaccine virus selection: report of a WHO informal consultation held at WHO headquarters, Geneva, Switzerland, 14-16 June 2010. Influenza Other Respir Viruses 2013; 7(Suppl 2):52-53.